EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Linagliptin as a Multi-Target Neuroprotective Agent in Cognitive Disorders: Molecular Mechanisms and Translational Challenges—A Narrative Review

Leila Mohammadi, Mehrdad Roghani, Tourandokht Baluchnejadmojarad

Drug Design, Development and Therapy · 2026-11 · Volume 20 · 1-13

DOI: 10.2147/dddt.s645071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-11. Verfasst von Leila Mohammadi und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Mohammadi, L., Roghani, M., & Baluchnejadmojarad, T. (2026). Linagliptin as a Multi-Target Neuroprotective Agent in Cognitive Disorders: Molecular Mechanisms and Translational Challenges—A Narrative Review. Drug Design, Development and Therapy, Volume 20, 1-13. https://doi.org/10.2147/dddt.s645071

Vancouver

Mohammadi L, Roghani M, Baluchnejadmojarad T. Linagliptin as a Multi-Target Neuroprotective Agent in Cognitive Disorders: Molecular Mechanisms and Translational Challenges—A Narrative Review. Drug Design, Development and Therapy. 2026;Volume 20:1-13. doi:10.2147/dddt.s645071

BibTeX
@article{Mohammadi2026,
  author = {Mohammadi, Leila and Roghani, Mehrdad and Baluchnejadmojarad, Tourandokht},
  title = {Linagliptin as a Multi-Target Neuroprotective Agent in Cognitive Disorders: Molecular Mechanisms and Translational Challenges—A Narrative Review},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--13},
  doi = {10.2147/dddt.s645071}
}
Kostenlos starten →